Dupixent (dupilumab) now reimbursed in Quebec
Dupixent™ (dupilumab) now publicly reimbursed in quebec for moderate-to-severe atopic dermatitis The Eczema Society of Canada is happy to share the exciting news that Dupixent™
Dupixent™ (dupilumab) now publicly reimbursed in quebec for moderate-to-severe atopic dermatitis The Eczema Society of Canada is happy to share the exciting news that Dupixent™
Eczema Society of Canada releases “A Day with Eczema” video in recognition of Eczema Awareness Month The video takes an intimate look into the life
November is Eczema Awareness Month and ESC wants to know: What is it like to live #ADaywithEczema? It’s more than just dry skin. November is
Sign up for Eczema Society of Canada’s e-newsletter to get the latest news and expert tips delivered right to your inbox.
